- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Post-transplant Lymphoproliferative Disorder in South Africa
Total 1057 results
-
Oncopeptides ABApproved for marketingRelapsed and/or Refractory Multiple MyelomaUnited States
-
Seagen Inc.Millennium Pharmaceuticals, Inc.CompletedLymphoma, Large-Cell, Anaplastic | Lymphoma, NK-cell | Lymphoma, T-cellUnited States, United Kingdom
-
Novartis PharmaceuticalsTerminatedSolid Tumors and LymphomasUnited States, Australia, Netherlands, Canada, Germany, Switzerland, Japan, Spain
-
AmgenCompletedNon-Hodgkin's LymphomaUnited States, Australia, Italy, United Kingdom, Germany, France
-
Ichnos Sciences SARecruitingRelapsed/Refractory Multiple MyelomaUnited States, Australia
-
AbbVieTerminatedCancer | Multiple Myeloma (MM)United States, Australia, France, Israel, Japan, Spain, Taiwan
-
Molecure S.A.RecruitingPulmonary SarcoidosisUnited States, United Kingdom
-
Eli Lilly and CompanyCompletedT-Cell Lymphoma | B-Cell LymphomaMexico, United States, Australia, Brazil, Peru
-
ADC Therapeutics S.A.TerminatedAcute Myeloid Leukemia | Acute Lymphoblastic LeukemiaUnited States
-
Gilead SciencesTerminatedNon-Hodgkin LymphomaUnited States, France
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedPain | Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Unspecified Adult Solid Tumor, Protocol Specific | Neurotoxicity | Multiple Myeloma and Plasma Cell Neoplasm | Lymphoproliferative Disorder | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
University of PittsburghNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Pharmacyclics LLC.CompletedMultiple MyelomaUnited States, Canada
-
SanofiCompletedPlasma Cell MyelomaUnited States
-
Jazz PharmaceuticalsCompletedAcute Myeloid Leukemia (AML) | Acute Lymphoblastic Leukemia (ALL) | Myelodysplastic Syndrome (MDS)United States
-
University of CincinnatiNational Center for Research Resources (NCRR); Office of Rare Diseases (ORD); FDA Office of Orphan Products DevelopmentCompletedLymphangioleiomyomatosisUnited States, Canada, Japan
-
Novartis PharmaceuticalsCompletedALK-activated TumorsFrance, Spain, Germany, Italy, Korea, Republic of, Canada, Australia, United Kingdom, Netherlands, United States
-
Merck Sharp & Dohme LLCActive, not recruitingHodgkin LymphomaUnited States, Brazil, Colombia, Czechia, France, Germany, Greece, Guatemala, Italy, Korea, Republic of, Mexico, Netherlands, Slovakia, South Africa, Spain, United Kingdom
-
Sierra Oncology LLC - a GSK companyCompletedLymphoma, Diffuse Large B-CellUnited States, Puerto Rico
-
BayerTerminatedLymphoma, Non-HodgkinUnited States, Hungary, China, Belgium, Korea, Republic of, France, Australia, Russian Federation, Taiwan, Denmark, Japan, United Kingdom, Spain, South Africa, Turkey, Romania, Singapore, Israel, Ireland, Canada, Poland, Greece, Cze... and more
-
Bristol-Myers SquibbAbbottTerminatedNewly Diagnosed, Previously Untreated Multiple MyelomaUnited States, Poland, Italy, Greece
-
OncotherapeuticsUnknownMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Completed
-
Novartis PharmaceuticalsCompleted
-
PfizerTerminatedNeoplasms MalignantUnited States, Korea, Republic of, Japan, China, Taiwan, Italy, Russian Federation
-
SanofiCompletedMultiple MyelomaFrance, Spain, Belgium, Australia, United States, Japan
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Allogene TherapeuticsRecruitingRelapsed/Refractory Large B Cell LymphomaBelgium, United States, Austria
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Aileron Therapeutics, Inc.CompletedLymphoma | Solid Tumor | Peripheral T-Cell LymphomaUnited States
-
CelgeneRecruitingLymphoma, B-CellUnited States, Greece, Spain, Australia, Poland, Taiwan, Korea, Republic of
-
University College, LondonUniversity of Miami; Takeda; European Organisation for Research and Treatment... and other collaboratorsRecruitingHodgkin LymphomaUnited Kingdom, New Zealand, Australia, United States, Belgium, Spain
-
AbbVieTerminatedMultiple MyelomaUnited States, Australia, France, Germany, Israel, Japan, Spain
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
BiogenCompletedNon-Hodgkin's LymphomaUnited States
-
Gilead SciencesTerminatedFollicular LymphomaSpain, Italy, France, Poland, Israel, United Kingdom, Czechia, Romania, Australia, Canada
-
Bristol-Myers SquibbOno Pharmaceutical Co. Ltd; Seagen Inc.Terminated
-
Array Biopharma, now a wholly owned subsidiary...CompletedMultiple Myeloma, Plasma Cell LeukemiaUnited States
-
Novartis PharmaceuticalsCompletedRelapsed or Refractory Multiple MyelomaUnited States, Turkey, Canada, Netherlands, Australia, Germany, France
-
Aptevo TherapeuticsTerminatedChronic Lymphocytic Leukemia | Peripheral T-cell LymphomaUnited States
-
National Cancer Institute (NCI)CompletedRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | CD20 PositiveUnited States
-
BioCryst PharmaceuticalsCompletedLeukemia, T-CellUnited States, Georgia
-
Acrotech Biopharma Inc.CompletedB-cell Lymphoma | Hodgkin's Lymphoma | Relapsed or Refractory Lymphoproliferative Malignancies | Peripheral T-cell Lymphoma | Waldenstrom's MacroglobulinemiaUnited States
-
Eastern Cooperative Oncology GroupTerminated
-
Otsuka Pharmaceutical Development & Commercialization...Center for International Blood and Marrow Transplant ResearchCompletedLymphomaUnited States, Canada
-
Chiron CorporationCompletedLymphoma, Non-HodgkinUnited States
-
CelgeneApproved for marketingMultiple MyelomaUnited States, Canada
-
Taunton and Somerset HospitalCompleted
-
Gilead SciencesTerminatedChronic Lymphocytic LeukemiaUnited States, Canada, Spain, Australia, Italy, United Kingdom, Belgium, Croatia, France, Hungary, Poland, Romania, Czechia
-
Kanecia Obie ZimmermanEnrolling by invitationLong COVID | Long Covid19United States, Puerto Rico